echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Genetron Health and Fosun Pharma reached an exclusive commercial cooperation on Seq-MRD®

    Genetron Health and Fosun Pharma reached an exclusive commercial cooperation on Seq-MRD®

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 22, Genetron Health announced that it had signed an exclusive commercial cooperation agreement with Jiangsu Fosun Pharmaceutical, a subsidiary of Shanghai Fosun Pharmaceutical Holdings, on Genetron Health's Seq-MRD® (hematological minimal residual disease) detection service


    According to the agreement, Genetron Health and Jiangsu Fosun Pharma will jointly sell and jointly promote Seq-MRD® in key hospitals and clinics for hematological diseases in designated areas in China to serve acute lymphoblastic leukemia, multiple myeloma, and chronic lymphocytic leukemia Waiting for patients with lymphatic hematological tumors


    In the process of cooperation, Jiangsu Fosun Pharma will use its clinics, hospitals and distributors and other terminal channel resources to gather a large-scale and experienced hematological tumor professional marketing team to serve the clinical promotion and market of the Seq-MRD® project Application


    Seq-MRD® is a molecular diagnostic method for detecting and monitoring minimal residual disease in specific hematological tumors


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.